BRPI0104491B8 - n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. - Google Patents
n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.Info
- Publication number
- BRPI0104491B8 BRPI0104491B8 BRPI0104491A BR0104491A BRPI0104491B8 BR PI0104491 B8 BRPI0104491 B8 BR PI0104491B8 BR PI0104491 A BRPI0104491 A BR PI0104491A BR 0104491 A BR0104491 A BR 0104491A BR PI0104491 B8 BRPI0104491 B8 BR PI0104491B8
- Authority
- BR
- Brazil
- Prior art keywords
- dimethylphenyl
- propyl
- obtaining
- piperidinocarboxamide
- enantiomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"processo de obtenção dos enantiômeros da n-(2,6dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção de misturas não racêmicas entre os enantiômeros da n-(2,6-dimetilfenil) -1-propil - 2 - piperidinocarboxamida; composto compreendendo misturas não racêmicas dos enantiômeros da n - (2, 6-dimetilfenil) - 1 - propil - 2 piperidinocarboxamida; composições farmacêuticas compreendendo misturas não racêmicas dos enantiômeros da n(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida". a presente invenção descreve um método de separação dos enantiômeros da n-(2,6-dimetilfenil)-1-propil-2piperidinocarboxamida. outro objeto da presente invenção refere-se a manipulação enantiomérica dos enantiômeros da n- (2, 6dimetilfenil)-1-propil-2-piperidinocarboxamida, no sentido de obter compostos e composições farmacêuticas apresentando excessos enantioméricos variados de (s)- n-(2,6dimetilfenil)-1-propil-2-piperidinocarboxamida, de forma quantificar e determinar a participação do (r)- n-(2,6dimetilfenil)-1-propil-2-piperidinocarboxamida nos efeitos anestésico e cardiotóxico. estes compostos e composições enantiomericamente manipulados demonstram apresentar uma melhoria significativa em suas propriedades anestésicas apresentando um perfil cardiotóxico equivalente ao enantiômero puro, a (s)- n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0104491A BRPI0104491B8 (pt) | 2001-10-10 | 2001-10-10 | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
| AT02805235T ATE414691T1 (de) | 2001-10-10 | 2002-10-08 | Verfahren zum erhalt von enantiomeren und nicht- razemischen mischungen der enantiomere von n-(2,6-dimethylphenyl)-1-propyl-2- piperidinocarbonsäureamid; nicht-razemische mischungen und pharmazeutische zusammenstellungen die diese enthalten. |
| DE60229968T DE60229968D1 (de) | 2001-10-10 | 2002-10-08 | Verfahren zum erhalt von enantiomeren und nicht-razemischen mischungen der enantiomere von n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarbonsäureamid; nicht-razemische mischungen und pharmazeutische zusammenstellungen die diese enthalten. |
| PCT/BR2002/000140 WO2003053326A2 (en) | 2001-10-10 | 2002-10-08 | Enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; its pharmaceutical compositions and processes of making them |
| US10/491,924 US7495105B2 (en) | 2001-10-10 | 2002-10-08 | Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositions |
| EP02805235A EP1434764B1 (en) | 2001-10-10 | 2002-10-08 | Process for obtainment of enantiomers-of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; non racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide;pharmaceuticals compositions comprising said non-racemic mixtures of enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide |
| AU2002333074A AU2002333074A1 (en) | 2001-10-10 | 2002-10-08 | Enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; its pharmaceutical compositions and processes of making them |
| HK05100159.2A HK1069818A1 (en) | 2001-10-10 | 2005-01-07 | Process for obtainment of enantiomers-of n-(2,6-dimethylphenyl)-1-propyl-2- piperidinocarboxamide; process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2- piperidinocarboxamide; non racemic mixtures of enantiomers of n-(2,6- dimethylphenyl)-1-propyl-2-piperidinocarboxamide; pharmaceuticals compositions comprising said non-racemic mixtures of enantiomers of n-(2,6- dimethylphenyl)-1-propyl-2-piperidinocarboxamide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0104491A BRPI0104491B8 (pt) | 2001-10-10 | 2001-10-10 | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0104491A BR0104491A (pt) | 2003-12-02 |
| BR0104491B1 BR0104491B1 (pt) | 2013-11-12 |
| BRPI0104491B8 true BRPI0104491B8 (pt) | 2021-05-25 |
Family
ID=3948021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0104491A BRPI0104491B8 (pt) | 2001-10-10 | 2001-10-10 | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7495105B2 (pt) |
| EP (1) | EP1434764B1 (pt) |
| AT (1) | ATE414691T1 (pt) |
| AU (1) | AU2002333074A1 (pt) |
| BR (1) | BRPI0104491B8 (pt) |
| DE (1) | DE60229968D1 (pt) |
| HK (1) | HK1069818A1 (pt) |
| WO (1) | WO2003053326A2 (pt) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695576A (en) | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
| SE451840B (sv) | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
| US5786484A (en) * | 1994-09-23 | 1998-07-28 | Chiroscience Limited | Racemization and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof |
| DE69531624T2 (de) | 1994-10-25 | 2004-06-17 | Darwin Discovery Ltd., Slough | Verfahren zur herstellung von levobupivacaine und analoge |
| CA2200355C (en) * | 1994-10-25 | 2007-03-06 | Marianne Langston | Crystallisation of levobupivacaine and analogues thereof |
| US6384227B2 (en) * | 1995-01-18 | 2002-05-07 | Darwin Discovery Ltd. | Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
| SE9501808D0 (sv) | 1995-05-16 | 1995-05-16 | Astra Ab | New process |
-
2001
- 2001-10-10 BR BRPI0104491A patent/BRPI0104491B8/pt not_active IP Right Cessation
-
2002
- 2002-10-08 AU AU2002333074A patent/AU2002333074A1/en not_active Abandoned
- 2002-10-08 US US10/491,924 patent/US7495105B2/en not_active Expired - Fee Related
- 2002-10-08 AT AT02805235T patent/ATE414691T1/de not_active IP Right Cessation
- 2002-10-08 EP EP02805235A patent/EP1434764B1/en not_active Expired - Lifetime
- 2002-10-08 WO PCT/BR2002/000140 patent/WO2003053326A2/en not_active Application Discontinuation
- 2002-10-08 DE DE60229968T patent/DE60229968D1/de not_active Expired - Lifetime
-
2005
- 2005-01-07 HK HK05100159.2A patent/HK1069818A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002333074A8 (en) | 2003-07-09 |
| EP1434764B1 (en) | 2008-11-19 |
| WO2003053326A3 (en) | 2004-03-04 |
| US20040210057A1 (en) | 2004-10-21 |
| EP1434764A2 (en) | 2004-07-07 |
| DE60229968D1 (de) | 2009-01-02 |
| ATE414691T1 (de) | 2008-12-15 |
| WO2003053326B1 (en) | 2004-04-08 |
| BR0104491A (pt) | 2003-12-02 |
| BR0104491B1 (pt) | 2013-11-12 |
| WO2003053326A2 (en) | 2003-07-03 |
| US7495105B2 (en) | 2009-02-24 |
| HK1069818A1 (en) | 2005-06-03 |
| EP1434764A4 (en) | 2005-06-01 |
| AU2002333074A1 (en) | 2003-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113989A (pt) | Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos | |
| ME00921B (me) | Asimetrična sinteza pregabalina | |
| EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
| SE9501567D0 (sv) | A new combination | |
| JO2605B1 (en) | Pyrrolidone derivatives as MAOB inhibitors | |
| BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
| PT1412341E (pt) | Processo de preparacao de citalopram racemico e/ou citalopram s ou por separacao de uma mistura de citalopram r e s | |
| BR0002246A (pt) | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis | |
| BRPI0416287A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização | |
| RU2004110041A (ru) | Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика | |
| DE60120109D1 (de) | Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin | |
| BRPI0417714A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR0110184A (pt) | Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes | |
| HUP0401934A2 (hu) | Enantiomerekben dúsított demetil- és didemetil- citalopram metabolitok alkalmazása depresszió és más központi idegrendszeri rendellenességek esetében | |
| BRPI0104491B8 (pt) | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. | |
| SI1525188T1 (sl) | Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo | |
| BRPI0408680A (pt) | processo para produzir álcoois e aminas enantiomericamente enriquecidos | |
| SE9804126D0 (sv) | New pharmaceutical composition | |
| BRPI0407529A (pt) | uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática | |
| PT1347960E (pt) | Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina | |
| SE9803157D0 (sv) | A new composition | |
| EE200400016A (et) | Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks | |
| PT1317427E (pt) | Processo para a producao de compostos quirais | |
| SE9803156D0 (sv) | A new composition | |
| BRPI0413484A (pt) | processo para preparação de n-arilmorfolinonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FBOS | Technical and formal requirements: other requirements | ||
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: ATRAVES DA PETICAO NO 027387, DE 19 DE MAIO DE 2004, A REQUERENTE SOLICITOU O EXAME DO PRESENTE PEDIDO E EFETUOU A RETRIBUICAO EQUIVALENTE A 10 REIVINDICACOES. NO ENTANTO, APESAR DE TER REQUERIDO O EXAME DE 4 REIVINDICACOES NA PETICAO SUPRACITADA, O QUADRO REIVINDICATORIO APRESENTADO ANTES DO PEDIDO DE EXAME POSSUI 14 REIVINDICACOES. LOGO, ENTENDE-SE QUE A REQUERENTE DESEJA QUE O EXAME SEJA REALIZADO NO UNICO QUADRO REIVINDICATORIO APRESENTADO. DESSE MODO, A FIM DE DAR CONTINUIDADE AO EXAME DO PRESENTE PEDIDO, O REQUERENTE DEVERA COMPLEMENTAR A RETRIBUICAO EQUIVALENTE A 4 REIVINDIACOES EXCEDENTES. |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE(S). |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2125 DE 27/09/2011. |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/11/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 10.10.2021 |